Both sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...

Lupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...

Carlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.

Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...

Indian firm Aurobindo Pharma has been dragged to court by three multi-national drug makers on allegations of patent infringement.

Zydus Hospitals & Healthcare Research recently started its first hospital operations at Anand, better known as Amul's hometown.

Zydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.

Sharekhan has recommended ‘buy’ on Cadila Healthcare with a target price of Rs.372. At the current market price of Rs272, the stock is avai...

The company plans to launch 100 drugs in US & Europe over the next five years.

One of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...